170498 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30 CD40 or CD95
Methods for Diagnosing and Treating Vestibular Schwannoma
#2METHODS FOR MEASURING LYMPHOCYTE ACTIVITY
#3DEVELOPMENT AND USE OF NOVEL MULTISPECIFIC TUMOR INHIBITOR
#4BIOMARKERS IN LONG-COVID-19
#5TACI ANTIBODY AND USE THEREOF
#6METHOD FOR SCREENING AND PREPARING IMMUNOMODULATOR
#7METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#8COMPOSITIONS AND METHODS FOR PLASMAPHERESIS
#9COMPOSITIONS AND METHODS FOR PLASMAPHERESIS
#10Skeletal Muscle-On-A-Chip In Microgravity As A Platform For Regeneration Modeling And Drug Screening
#11COMPOSITIONS AND METHODS FOR ANALYSIS, DETECTION, AND TREATMENT OF MULTIPLE SCLEROSIS
#12NEUTRALIZATION ANTIBODY ASSAY METHOD
#13COMPOSITIONS AND METHODS FOR PLASMAPHERESIS
#14COMPOSITIONS AND METHODS FOR PLASMAPHERESIS
#15METHODS OF TREATING A NON-SMALL CELL LUNG CANCER USING AN ANTI-PD-1 ANTIBODY
#16ANTI-CD40 ANTIBODY, ANTI-PD-L1×CD40 BISPECIFIC ANTIBODY, AND USE THEREOF
#17METHODS AND COMPOSITIONS FOR MONITORING THE TREATMENT OF RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
#18METHODS OF DIAGNOSING AND TREATING MULTIPLE SCLEROSIS BY DETECTING A BIOMARKER IN THE CEREBROSPINAL FLUID
#19METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#20THERAPEUTIC ANTIBODIES
#21METHOD FOR TESTING TERTIARY LYMPHOID TISSUE, AND KIT FOR TESTING TERTIARY LYMPHOID TISSUE
#22LIQUID BIOPSY FOR DIAGNOSIS OF EARLY OSTEOARTHRITIS
#23METHOD FOR DETERMINING THE PROGNOSTIC SCORE IN PATIENTS WITH METASTATIC RENAL CARCINOMA
#24BCMA ANTIBODY AND USE THEREOF
#25ANTIBODIES AND BISPECIFIC BINDING PROTEINS THAT BIND OX40 AND/OR PD-L1
#26CLINICAL TIER GRADING FOR PROGNOSIS OF IMMUNE CHECKPOINT INHIBITOR EFFICACY AND CLINICAL STATUS
#27GENE USING BCMA EXTRACELLULAR DOMAIN AS MARKER, POLYPEPTIDE, RECOMBINANT EXPRESSION VECTOR, GENETICALLY ENGINEERED CELL, AND USE THEREOF
#28ANTIBODIES THAT BIND TO OX40 AND THEIR USES
#29PREDICTIVE RESPONSE BIOMARKER DISCOVERY PROCESS
#30ANTIGEN BINDING PROTEIN TARGETING CD40, AND PREPARATION THEREFOR AND USE THEREOF
#31ANTI-BCMA CAR ANTIBODIES, CONJUGATES, AND METHODS OF USE
#32ANTI-CD40 NANOBODY, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#33ORAL MESENCHYMAL STEM CELLS AND USE THEREOF
#34METHODS FOR ENHANCED BCMA IMMUNOHISTOCHEMISTRY DETECTION IN HUMAN AND MONKEY TISSUE
#35ANTIBODY TARGETING B CELL MATURATION ANTIGEN AND RELATED PRODUCTS THEREOF AND MEDICAL APPLICATIONS
#36BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA DIAGNOSTIC TEST
#37BIOMARKERS AND TREATMENT METHODS FOR TRAUMATIC BRAIN INJURY-ASSOCIATED IMPAIRMENTS
#38PLATFORM FOR ANTIBODY DISCOVERY
#39ANTI-BCMA NANOBODY AND USE THEREOF
#40PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS
#41Compositions and methods for plasmapheresis
#42EARLY DIAGNOSIS OF INFECTIONS
#43Biomarker for Regulatory T Cell
#44BIODOSIMETRY PANELS AND METHODS
#45Anti-HVEM Antibodies
#46Compositions and methods for plasmapheresis
#47BATCH RELEASE ASSAY FOR PHARMACEUTICAL PRODUCTS RELATING TO T CELL THERAPIES
#48MARKERS OF AUTOIMMUNE DISEASES
#49METHOD OF DETERMINING PROGNOSIS OF CHRONIC KIDNEY DISEASE
#50ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF
#51BIOMARKERS OF RENAL INJURY
#52CD40 BINDING MOLECULES AND USES THEREOF
#53METHOD FOR PREDICTING THE FERTILITY POTENTIAL OF A FEMALE SUBJECT
#54METHODS FOR CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS
#55ANTI-HUMAN B CELL MATURATION ANTIGEN (BCMA) ANTIBODIES AND THEIR USE IN IMMUNOHISTOCHEMISTRY (IHC)
#56KIDNEY FUNCTION BIOMARKERS
#57B CELL MONITORING REAGENT PANEL AND REAGENT KIT FOR ANALYZING B CELL SUBSETS IN ANTI-CD20 TREATED AUTOIMMUNE PATIENTS
#58USES OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPIES IN COMBINATION WITH INHIBITORS OF INFLAMMATION-RELATED SOLUBLE FACTORS
#59METHOD FOR PREDICTING PATIENT RESPONSE TO CD40-TARGETED THERAPIES
#60METHODS AND COMPOSITIONS FOR THE TREATMENT OF CROHN'S DISEASE
#61BIOMARKER METHODS AND USES
#62METHOD FOR DETECTING INFLAMMATION-RELATED PLATELET ACTIVATION
#63METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING A CANCER
#64METHODS OF DIAGNOSING AND TREATING LUPUS
#65Antibodies binding TNFR2 and uses thereof
#66KIDNEY HEALTH MONITORING IN HYPERTENSION PATIENTS
#67Composition for preventing or treating diseases caused by overexpression of chemokine CXCL1, containing death receptor inhibitor as active ingredient
#68ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF
#69ANTI-GITR ANTIBODIES AND METHODS OF USE THEREOF
#70METHODS FOR EVALUATION OF THE EFFECTIVENESS OF A DRUG OR DRUG CANDIDATE IN TREATING AN INFLAMMATORY BOWEL DISEASE BY USE OF A MULTIPLEXED ASSAY KIT COMPRISING VARIOUS BIOMARKERS
#71Antibodies that bind to OX40 and their uses
#72Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#73DETECTION AND TREATMENT OF CD30+ CANCERS
#74METHODS AND COMPOSITIONS FOR MONITORING THE TREATMENT OF RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
#75BIOMARKER COMBINATIONS IN EX VIVO LUNG PERFUSION (EVLP) PERFUSATE
#76Antibodies targeting B-cell maturation antigen and methods of use
#77ANTI-CD40 ANTIBODIES AND USES THEREOF
#78SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
#79SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
#80Early diagnosis of infections
#81METHODS AND COMPOSITIONS FOR IDENTIFYING WHETHER A SUBJECT SUFFERING FROM A CANCER WILL ACHIEVE A RESPONSE WITH AN IMMUNE-CHECKPOINT INHIBITOR
#82SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
#83SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
#84SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
#85SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
#86Protein signatures for distinguishing between bacterial and viral infections
#87Diagnosis method of multiple sclerosis
#88Nidogen 1 as a diagnostic marker and therapeutic target of hepatocellular carcinoma, composition and methods thereof
#89Anti-OX40 antibody
#90Anti-BCMA CAR antibodies, conjugates, and methods of use
#91Anti-BCMA single-chain antibody scFv and preparation method and application thereof
#92CD33 MONOCYTES AS A BIOMARKER
#93Serum biomarkers for predicting and evaluating response to TNF inhibitor therapy in rheumatoid arthritis patients
#94Biomarkers and treatment methods for traumatic brain injury-associated impairments
#95System and method for removal of immune inhibitors from biological fluids
#96SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
#97Biomarkers for graft-versus-host disease
#98High-throughput method to screen cognate T cell and epitope reactivities in primary human cells
#99Anti-GITR antibodies and methods of use thereof
#100BIOMARKER COMBINATION FOR IDENTIFICATION OF "AT-RISK" SUBJECTS FOR AKI
#101Anti-GITR antibodies for cancer diagnostics
#102CD153 AND/OR CD30 IN INFECTION
#103Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#104BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA FOR USE IN TREATMENT OF DISEASES
#105Anti-GITR antibodies and methods of use thereof
#106Methods of administering anti-OX40 antibodies
#107METHODS FOR EVALUATION OF THE EFFECTIVENESS OF A DRUG OR DRUG CANDIDATE IN TREATING AN INFLAMMATORY BOWEL DISEASE BY USE OF A MULTIPLEXED ASSAY KIT COMPRISING VARIOUS BIOMARKERS
#108DIAGNOSIS OF CROHN'S DlSEASE AND ULCERATIVE COLITIS
#109Vectors comprising nucleic acids encoding anti-OX40 antibodies
#110BIOMARKERS IN EX VIVO LUNG PERFUSION (EVLP) PERFUSATE
#111Biomarkers of renal injury
#112SRM/MRM Assay for the Tumor Necrosis Factor Receptor Superfamily Member 8 (CD30) Protein
#113Compositions and Methods for Assessing Acute Kidney Injury (AKI) and Mortality Risk
#114Antibodies targeting b-cell maturation antigen and methods of use
#115Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
#116Detection and treatment of CD30 cancers
#117Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
#118Antibodies that bind to OX40 and their uses
#119RESIDUAL DISEASE DETECTION IN MULTIPLE MYELOMA
#120Biodosimetry panels and methods
#121Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
#122Nucleic acids encoding anti-OX40 antibodies
#123Methods for the identification, targeting and isolation of human dendritic cell (DC) precursors “pre-DC” and their uses thereof
#124Anti-GITR antibodies and methods of use thereof
#125Anti-OX40 antibodies
#126Early diagnosis of infections
#127METHOD FOR THE PROGNOSIS OF MULTIPLE MYELOMA
#128Protein signatures for distinguishing between bacterial and viral infections
#129Diagnostic, prognostic, and monitoring methods for chronic lymphocytic leukemia
#130METHODS OF DIAGNOSING AND TREATING LUPUS
#131Polypeptides and uses thereof for reducing CD95-mediated cell motility
#132Anti-GITR antibodies and methods of use thereof
#133Anti-GITR antibodies and methods of use thereof
#134Methods of identifying immune cells in PD-L1 positive tumor tissue
#135Anti-GITR antibodies and methods of use thereof
#136INTERCELLULAR LABELING OF LIGAND-RECEPTOR INTERACTIONS
#137Prognostic method
#138Kit for immunological detection of TNF-alpha, sTNFR1 and IL-8 in prostate cancer
#139Biodosimetry panels and methods
#140Methods for enhancing anti-tumor antibody therapy
#141Anti-OX40 antibodies and diagnostic uses thereof
#142Anti-GITR antibodies for cancer diagnostics
#143Methods and compositions for obtaining a tuberculosis assessment in a subject
#144KIDNEY FUNCTION BIOMARKERS
#145Biomarkers for determining the clinical response to cell therapy
#146Serum biomarker panels for bipolar disorder
#147Detection of ovarian cancer using antibody arrays
#148Antibodies targeting B-cell maturation antigen and methods of use
#149Methods for evaluation of the effectiveness of a drug or drug candidate in treating an inflammatory bowel disease by use of multiplexed assay kit comprising various biomarkers
#150BISPECIFIC ANTIBODY BINDING TO TRAILR2 AND PSMA
#151Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
#152B-cell antigen presenting cell assay
#153Method for assessing therapeutic effect of anti-cancer agent having anti-CD4 antibody as active ingredient
#154BISPECIFIC ANTIBODIES AGAINST CD3 EPSILON AND BCMA FOR USE IN TREATMENT OF DISEASES
#155CELL SENESCENCE MARKERS AS DIAGNOSTIC AND THERAPEUTIC TARGETS
#156Analytical Methods and Arrays for Use in the Same
#157METHOD FOR PRODUCING AUTOLOGOUS TOLEROGENIC DENDRITIC CELLS (TOLDCS) WITH SPECIFIC ANTIGENS AND THEIR USE IN THE PREPARATION OF A MEDICAMENT USEFUL FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
#158Biomarker-based methods for aiding the diagnosis of stroke
#159Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#160Diagnosis and treatment of Kawasaki disease
#161Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
#162USE OF BIOMARKERS FOR DETECTION OF EXCESSIVE ALCOHOL USE
#163Polypeptides and uses thereof for reducing CD95-mediated cell motility
#164Cell-surface marker of early MSC aging
#165Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
#166Anti-CD40 antibodies
#167Anti-OX40 antibodies
#168MRM/SRM assay for death receptor 5 protein
#169Anti-DR6 antibodies and methods of immune regulation
#170COMPOSITIONS AND METHODS FOR TREATING IMMUNE AND VIRAL DISORDERS AND MODULATING PROTEIN-RNA INTERACTION
#171MARKER FOR PREDICTING METASTASIS OF BREAST CANCER
#172Detection of ovarian cancer using antibody arrays
#173FasR antibodies and methods of use
#174Biomarkers for prostate cancer comprising interleukin-8 (IL-8), tumor necrosis factor alpha and soluble tumor necrosis factor-alpha receptor 1
#175B-cell antigen presenting cell assay
#176METHODS FOR DIAGNOSIS OF CUTANEOUS T-CELL LYMPHOMA
#177Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
#178Diagnostic, prognostic, and monitoring methods for multiple myeloma, chronic lymphocytic leukemia, and B-cell non-hodgkin lymphoma
#179SYSTEMS AND METHODS FOR DIAGNOSING AND TREATING CANCER
#180Systems and methods for characterizing kidney diseases
#181Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo
#182Intercellular labeling of ligand-receptor interactions
#183Methods for enhancing anti-tumor antibody therapy
#184Quantification of misfolded TNFR2:Fc
#185Biodosimetry panels and methods
#186Biomarkers and methods for measuring and monitoring inflammatory disease activity
#187METHOD TO IDENTIFY PATIENTS THAT WILL LIKELY RESPOND TO ANTI-TNF THERAPY
#188Anti-GITR antibodies and methods of use thereof
#189Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
#190Multi-aptamer-based, cell-specific, one-step tumor cell detection assays
#191METHODS OF PROGNOSTICATING AND TREATING CANCER
#192BIOMARKERS FOR OVARIAN CANCER
#193Diagnosis and risk stratification of bladder cancer
#194MARKER ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS
#195MULTIPLEXED METHOD FOR DIAGNOSING CLASSICAL HODGKIN LYMPHOMA
#196CANCER PROGNOSTIC ASSAYS
#197KIDNEY FUNCTION BIOMARKERS
#198SYSTEMS AND METHODS FOR CHARACTERIZING LUPUS ERYTHEMATOSUS
#199Multiplexed assay kit to evaluate the efficacy of treatment for inflammatory bowel disease
#200Detection and treatment of CD30 cancers
#201Soluble CD27 (sCD27) and the use thereof
#202Methods of modulating HVEM, BTLA and CD160 cis complex response or signaling activity with soluble light polypeptide sequences
#203Levels of BLyS/APRIL heterotrimers in serum and use in diagnostic methods
#204Agents and methods related to screening for resistance to DR5 and reducing resistance to DR5 agonists
#205B-cell antigen presenting cell assay
#206METHODS OF IDENTIFYING OBM MODULATORS
#207Methods for enhancing anti-tumor antibody therapy
#208Compounds inhibiting CD95 signaling for the treatment of pancreatic cancer
#209METHODS OF MODULATING THE OX40 RECEPTOR TO TREAT CANCER
#210Marker associated with non-alcoholic steatohepatitis
#211Systems and methods for characterizing kidney diseases
#212Vaccine targeting cellular death receptor DR5
#213Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists
#214Anti-CD27 humanized monoclonal antibody
#215Biomarkers of renal injury
#216BIOMARKERS
#217BIOMARKERS FOR PREDICTING SUSTAINED RESPONSE TO HCV TREATMENT
#218SYSTEMS AND METHODS FOR CHARACTERIZING LUPUS ERYTHEMATOSUS
#219METHODS FOR PREDICTING DEVELOPMENT OF AUTO-IMMUNE DISEASES AND TREATMENT OF SAME
#220Method of treating CD40-mediated diseases
#221Biomarkers and methods for measuring and monitoring inflammatory disease activity
#222Agonistic binding molecules to the human OX40 receptor
#223HVEM/BTLA, HVEM/CD 160 and HVEM/gD cis complexes and methods of use
#224METHODS OF MODULATING THE OX40 RECEPTOR TO TREAT CANCER
#225Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo
#226DIAGNOSTIC TEST
#227METHOD OF MONITORING HIV INFECTION
#228Methods of use of the TACI/TACI-L interaction
#229Anti-CD27 antibody
#230ANTIBODIES THAT BIND TO OBM
#231Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists
#232METHODS OF MODULATING HVEM, BTLA AND CD160 CIS COMPLEX RESPONSE OR SIGNALING ACTIVITY WITH SOLUBLE LIGHT POLYPEPTIDE SEQUENCES
#233Amelioration of Inflammatory Arthritis By Targeting the Pre-ligand Assembly Domain (Plad) of Tumor Necrosis Factor Receptors
#234LEVELS OF BLyS/APRIL HETEROTRIMERS IN SERUM AND USE IN DIAGNOSTIC METHODS
#235Identification of substances that inhibit NEMO oligomerization
#236Semi-quantitative immunochromatographic device and method for the determination of HIV/AIDS immune-status via measurement of soluble CD40 Ligand/CD154, A CD4+ T cell equivalent and the simultaneous detection of HIV infection via HIV antibody detection
#237Method for detecting antigen specific or mitogen-activated T cells
#238SYSTEMS AND METHODS FOR CHARACTERIZING KIDNEY DISEASE
#239Methods for diagnosis and treatment of epithelial-derived cancers
#240Semi-quantitative immunochromatographic device and method for the determination of HIV/AIDS immune-status via measurement of soluble CD40 ligand/CD 154, A CD4+T cell equivalent
#241Chemokine binding activity of viral TNF receptors and related proteins
#242Methods of use of the TACI/TACI-L interaction
#243Method to Identify CD40-Sensitive Cells Using Gene Expression
#244Antibodies to OCIF-binding molecules
#245Assay for Antibodies
#246Identification of substances that inhibit NEMO oligomerization
#247Method for treating an immune disorder by decreasing NIK-SIVA complex formation
#248Systems and methods for characterizing kidney diseases
#249Methods and compositions related to B cell assays
#250TGFBeta
#251HPV CD8+ T-cell epitopes
#252Compositions and methods to diagnose and treat lung cancer
#253Methods for predicting development of auto-immune diseases and treatment of same
#254Assay for Antibodies
#255Multimarker panel for diabetes type 1 and 2
#256Antibodies to OCIF-binding molecules
#257Antibody to the human OX40 receptor
#258Methods for distinguishing type-1 from type-2 diabetes
#259Diagnostic test
#260β2-adrenergic receptor agonists
#261Methods of designing and producing novel compounds having improved binding affinity for CD154 or other trimeric proteins
#262Treating autoimmune diseases with humanized anti-CD401 antibodies
#263Humanized antibodies to human GP39, compositions, and therapeutic uses thereof
#264Methods to diagnose and treat lung cancer
#265Use of molecular markers for the preclinical and clinical profiling of inhibitors of enzymes having histone deacetylase activity
#266Assay for antibodies
#267Agonists and antagonists of ryzn for the treatment of metabolic disorders
#268TNFr/OPG-like molecules and uses thereof
#269Multimarker panel for diabetes type 1 and 2
#270Biomarkers for age-related macular degeneration (AMD)
#271β2-adrenergic receptor agonists
#272Novel protein and method for producing the protein
#273Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
#274HPV CD8+ T-cell epitopes
#275Systems and methods for characterizing kidney diseases
#276Methods for diagnosis and treatment of epithelial-derived cancers
#277Methods for diagnosis and treatment of epithelial-derived cancers
#278Therapeutic applications for the anti-T-BAM (CD40-1) monoclonal antibody 5C8
#279Human tumor necrosis factor receptors TR21 and TR22
#280Agonists and antagonists of prolixin for the treatment of metabolic disorders
#281Agent controlling the production of osteoclast formation regulator and method of screening substance capable of controlling the production of osteoclast formation regulator
#282Agonists and antagonists of moxifin for the treatment of metabolic disorders
#283Antibodies to OCIF-binding molecules
#284Systems and methods for measuring changes in cellular activity in live tissue
#285Quantification of misfolded TNFR2:Fc